Organization: Natural Sciences and Engineering Council of Canada

The Short Report – May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more

Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.